SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001590750-20-000109
Filing Date
2020-11-13
Accepted
2020-11-13 16:15:30
Documents
16
Period of Report
2020-11-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgen-20201112.htm   iXBRL 8-K 42911
2 EX-3.1 mgen202011138kex31.htm EX-3.1 14186
8 mgen-20201112_g1.jpg GRAPHIC 5076
  Complete submission text file 0001590750-20-000109.txt   221511

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20201112.xsd EX-101.SCH 2444
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20201112_cal.xml EX-101.CAL 724
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20201112_def.xml EX-101.DEF 1657
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20201112_lab.xml EX-101.LAB 24977
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20201112_pre.xml EX-101.PRE 13201
9 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20201112_htm.xml XML 11486
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 201311667
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences